Music for Sleep-onset Insomnia

December 19, 2023 updated by: University of Aarhus

God Nat - God Dag. A Randomized Controlled Trial of Bedtime Music as Early Intervention for Sleep-onset Insomnia

The study is a randomized controlled trial evaluating the effect of bedtime music as an early intervention for sleep-onset insomnia in adults. The investigators use a randomized controlled trial design with two parallel groups. All participants receive sleep hygiene advice as standard treatment and participants in the intervention group are additionally asked to listen to a sleep playlist daily at bedtime. Subjective and objective sleep measures are evaluated before and after the 4 weeks intervention period. In addition, follow-up measures of subjective outcomes are assessed 4 weeks after the end of the intervention period.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Aarhus, Denmark, 8000
        • Aarhus University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Sleep-onset insomnia for 3-18 months

Exclusion Criteria:

  1. use of medications (benzodiazepines, z-drugs, antidepressive and anti-psychotic drugs)
  2. alcohol or substance abuse
  3. pregnant or breastfeeding women
  4. other sleep disorders (e.g. sleep apnea, restless leg syndrome, etc.)
  5. current psychiatric disorder or a history of psychotic disorders
  6. somatic disorders interfering with sleep (e.g. critical illness, pain disorders, neuro-degenerative disorders)
  7. shift work.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Control
Treatment as usual including sleep hygiene advice
Participants receive standard sleep hygiene advice.
Experimental: Intervention
Treatment as usual (sleep hygiene advice) and bedtime music listening
Participants receive standard sleep hygiene advice.
Participants in the intervention group listen to their preferred sleep playlist daily at bedtime for minimum 30 minutes.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Insomnia severity
Time Frame: Change from baseline to after the 4-week intervention period.
Measured with the Insomnia Severity Index, range 0-28 with higher scores indicating more severe insomnia.
Change from baseline to after the 4-week intervention period.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sleep quality
Time Frame: Change from baseline to after the 4-week intervention period.
Measured with the Pittsburgh Sleep Quality Index, range 0-21 with higher scores indicating more sleep problems.
Change from baseline to after the 4-week intervention period.
Sleep initiation difficulties
Time Frame: Change from baseline to after the 4-week intervention period.
Difficulties initiating sleep as measured with Pittsburgh Sleep Quality Index subscale
Change from baseline to after the 4-week intervention period.
Objective sleep quality
Time Frame: Change from baseline to after the 4-week intervention period.
Objective sleep quality as measured with polysomnography
Change from baseline to after the 4-week intervention period.
Sleep-wake pattern
Time Frame: Change from baseline to after the 4-week intervention period.
Sleep-wake pattern as measured with wrist-actigraphy
Change from baseline to after the 4-week intervention period.
Quality of life
Time Frame: Change from baseline to after the 4-week intervention period.
Quality of life as measured with SF-36, range 0-100 with higher scores indicating better quality of life.
Change from baseline to after the 4-week intervention period.
Pre-sleep arousal
Time Frame: Change from baseline to after the 4-week intervention period.
Pre-sleep arousal as measured with the Pre-Sleep Arousal Scale, range 8-40 with higher scores indicating higher pre-sleep arousal.
Change from baseline to after the 4-week intervention period.

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Depressive symptoms
Time Frame: Change from baseline to after the 4-week intervention period.
Depressive symptoms as measured with Beck Depression Inventory II, range 0-63 with higher scores indicating more severe depression.
Change from baseline to after the 4-week intervention period.
Anxiety
Time Frame: Change from baseline to after the 4-week intervention period.
Anxiety as measured with the State-Trait Anxiety Inventory, range 0-80 with higher scores indicating more anxiety.
Change from baseline to after the 4-week intervention period.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Kira V Jespersen, PhD, University of Aarhus

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2021

Primary Completion (Actual)

April 10, 2023

Study Completion (Actual)

June 2, 2023

Study Registration Dates

First Submitted

September 29, 2020

First Submitted That Met QC Criteria

October 6, 2020

First Posted (Actual)

October 14, 2020

Study Record Updates

Last Update Posted (Estimated)

December 20, 2023

Last Update Submitted That Met QC Criteria

December 19, 2023

Last Verified

December 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Insomnia

Clinical Trials on Sleep hygiene advice

Subscribe